Patrick Murphy

Etoposide: four decades of development of a topoisomerase II inhibitor

Targeted therapies in breast cancer: are heart and vessels also being targeted?

Disability in Restorative Proctocolectomy Recipients Measured using the Inflammatory Bowel Disease Disability Index

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.

Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer

Lung cancer: current therapies and new targeted treatments

Pharmacodynamic modeling of prolonged administration of etoposide

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer

Ulcerative colitis

Vinflunine

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide.

Virtual Reality Metaverse System Supplementing Remote Education Methods: Based on Aircraft Maintenance Simulation

Role of immersive technologies in healthcare education during the COVID-19 epidemic

Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?

Combination therapy in combating cancer

Natural product and natural product derived drugs in clinical trials

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer

Quality of Life After Total Proctocolectomy With Ileostomy or IPAA

Evaluation of an augmented reality platform for austere surgical telementoring: a randomized controlled crossover study in cricothyroidotomies

Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer

Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy

Phase I/II Study of Panobinostat and Carfilzomib in Patients (pts) with Relapsed or Refractory Multiple Myeloma (MM), Interim Phase I Safety Analysis